Reducing Asthma Disparities by Improving Provider-Patient Communication

Completed

• Conditions: Asthma

• Registration Number: NCT00181194
• Lead Sponsor: Johns Hopkins University

Brief Summary

The purpose of this study will be to assess the impact of a culturally-sensitive, patient-focused asthma communication instrument (ACCI) designed to enhance provider-patient communication by prompting and guiding providers in assessments of disease severity and discussion of adherence behaviors with minority patients with asthma.

Detailed Description

Improving communication between health care providers and their patients is the critical first step in efforts designed to reduce asthma-related health disparities in urban areas. Improving communication will help providers tailor asthma therapies to their patients' needs, and help providers and patients to overcome barriers (e.g., concerns about adverse effects) to adherence with those asthma treatment plans.

Study Timeline

• Study Start: 2005-05
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-16
• Primary Completion: 2006-12
• Study Completion: 2012-12
• Status Verified: 2018-08
• Last Update Submitted: 2018-08-17
• Last Update Posted: 2018-08-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 350

Inclusion Criteria

• are able to provide informed consent;
• report physician-diagnosed asthma;
• report asthma symptoms and/or use of short-acting reliever medication at least twice weekly in the past month.

Exclusion Criteria

• state they do not have asthma;
• have mild intermittent disease
• no recent evidence of disease activity.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Accuracy of Clinician Assessment of Patient Adherence
Patient satisfaction with provider-patient communication and medical care
Accuracy of Provider Assessment of Asthma Severity
Assessment of appropriateness of asthma treatment (consistency of care with asthma guidelines

Secondary Outcome Measures

Name	Time	Method
These outcomes include indicators of poor asthma control such as health care service use for asthma exacerbations (unscheduled office visits, ER visits, hospitalizations) and use of oral corticosteroid and overuse of inhaled beta-agonist medications.

Trial Locations

Locations (1)

Johns Hopkins Asthma And Allergy Center; 🇺🇸 Baltimore, Maryland, United States